SCHEMBL7567175

SCHEMBL7567175

CCOC(=O)CN(C)Cc1c(C)ccc([N+](=O)[O-])c1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 2/20 0.52
GRIA2 P42262 2/20 0.52
GRIA3 P42263 2/20 0.52
GRIA4 P48058 2/20 0.52
MAPT P10636 6/20 0.40
ALDH1A1 P00352 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
PTBP1 P26599 1/20 0.37
HTT P42858 1/20 0.37
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
RAB9A P51151 1/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7566388 0.78 GRIA1 (0.49) GRIA1GRIA2GRIA3GRIA4MAPT
SCHEMBL27457814 0.78 BCL9 (0.38) GRIA1GRIA2GRIA3GRIA4MAPT
SCHEMBL8548663 0.73 ALDH1A1 (0.41) MAPTALDH1A1LMNAMAPK1CYP3A4
SCHEMBL9231432 0.72 THRB (0.39) MAPTALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL3153696 0.72 PYCR1 (0.52) GRIA1GRIA2GRIA3GRIA4MAPT
SCHEMBL7469818 0.72 TSHR (0.47) MAPTALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL7563841 0.71 ALDH1A1 (0.46) GRIA1GRIA2GRIA3GRIA4MAPT
SCHEMBL7466959 0.70 TSHR (0.49) MAPTALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL5740363 0.70 GRIA1 (0.45) GRIA1GRIA2GRIA3GRIA4MAPT
SCHEMBL7566838 0.69 TSHR (0.47) MAPTALDH1A1SMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1125818-C Amino acid derivatives of substituted quinoxaline 2, 3 -dione derivativesa as glutamate receptor antagonists WARNER LAMBERT CO (US) 2003-10-29 CN disclosed
EP-0832074-B1 AMINO ACID DERIVATIVES OF SUBSTITUTED QUINOXALINE 2,3-DIONE DERIVATIVES AS GLUTAMATE RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 2002-09-04 EP disclosed
CN-1187190-A Amino acid derivatives of substituted quinoxaline 2, 3-dione derivatives as glutamate receptor antagonists WARNER LAMBERT CO (US) 1998-07-08 CN disclosed
US-5614508-A ANTIISCHEMIC AGENTS, ALZHEIMERS, STROKE OR NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1997-03-25 US disclosed
WO-1996040649-A1 AMINO ACID DERIVATIVES OF SUBSTITUTED QUINOXALINE 2,3-DIONE DERIVATIVES AS GLUTAMATE RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1996-12-19 WO disclosed